<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-259
Date of Submission: 2024-12-26

This report was submitted by a Patient from Olson Group Medical Center concerning patient ANON-PX-3758. The subject is a 87-year-old other with a significant medical history including chronic kidney disease, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Atorvastatin administered via the Subcutaneous route at a dosage of 432mg, initiated on 2024-10-24 for Hypercholesterolemia and discontinued on 2024-11-22.

On approximately 2024-11-11, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Somnolence, Hepatotoxicity, Maculopapular Rash, Vomiting, Dizziness. The Somnolence was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Hepatotoxicity was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Maculopapular Rash was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Vomiting was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed information and advised future. The current patient status regarding this symptom is 'Fatal'. The Dizziness was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed measure and advised human. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 9 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Form boy plan heavy entire attention. Population bag customer read together test care. Explain send bag present field.</data>
report_id: ADR-2024-259
report_date: '2024-12-26'
patient_details:
  patient_id: ANON-PX-3758
  gender: Other
  relevant_history:
  - chronic kidney disease
  - hypertension
  age_at_reaction: 87
suspected_drugs:
- drug_name: Atorvastatin
  dosage: 432mg
  route_of_administration: Subcutaneous
  start_date: '2024-10-24'
  indication_for_use: Hypercholesterolemia
  end_date: '2024-11-22'
adverse_reactions:
- symptom_name: Somnolence
  onset_date: '2024-11-11'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Hepatotoxicity
  onset_date: '2024-11-11'
  severity: Moderate
  outcome: Unknown
  intervention_required: false
- symptom_name: Maculopapular Rash
  onset_date: '2024-11-11'
  severity: Severe
  outcome: Fatal
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2024-11-11'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: true
  intervention_details: Prescribed information and advised future.
- symptom_name: Dizziness
  onset_date: '2024-11-11'
  severity: Moderate
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed measure and advised human.
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 9
reporting_facility: Olson Group Medical Center
reporter_type: Patient
notes: Form boy plan heavy entire attention. Population bag customer read together
  test care. Explain send bag present field.
